Sunshine Heart Inc. (SSH)
-NasdaqCM 6.27 
0.25(4.21%) 12:45PM EDT - Nasdaq Real Time Price
| Prev Close: | 6.02 |
|---|
| Open: | 6.17 |
|---|
| Bid: | 6.26 x 900 |
|---|
| Ask: | 6.29 x 900 |
|---|
| 1y Target Est: | 13.08 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 6.07 - 6.39 |
|---|
| 52wk Range: | 2.50 - 17.25 |
|---|
| Volume: | 148,632 |
|---|
| Avg Vol (3m): | 83,384 |
|---|
| Market Cap: | 59.66M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.80 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Value Investors Take Note: Fire Sale On This Heart Failure Assetat Seeking Alpha(Mon, May 20)
- SUNSHINE HEART, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Johnson & Johnson: At The Crossroads - Part IIIat Seeking Alpha(Thu, May 16)
- Sunshine Heart Quietly Reports Breakthrough In Congestive Heart Failure Treatmentat Seeking Alpha(Wed, May 15)
- SUNSHINE HEART, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhiEDGAR Online(Wed, May 15)
- Sunshine Heart Announces Corporate Updates and First Quarter 2013 Financial ResultsGlobeNewswire(Tue, May 14)
- SUNSHINE HEART, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, May 14)
- Johnson & Johnson: At The Crossroads - Part IIat Seeking Alpha(Fri, May 10)
- Sunshine Heart, Inc. Announces First Patient Implanted in C-Pulse System European Post-Market StudyMarketwired(Thu, May 9)
- Heartware Q1 Results: Good News For All LVAD Companiesat Seeking Alpha(Fri, May 3)
- Sunshine Heart, Inc. Closes Public Offering of Common SharesMarketwired(Tue, Apr 16)
- Sunshine Heart: A 'Buy The Dips' Pick That Could Pay Offat Seeking Alpha(Mon, Apr 15)
- SUNSHINE HEART, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial StatemenEDGAR Online(Thu, Apr 11)
- Stock Watch Thursday, 11 April 2013at Seeking Alpha(Thu, Apr 11)
- Sunshine Heart 2.5M share Spot Secondary priced at $5.25theflyonthewall.com(Thu, Apr 11)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.85 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.46 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Sunshine Heart, Inc., an early-stage medical device company, focuses on developing, manufacturing, and commercializing C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure.
View More